High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High‐Sensitive C‐Reactive Protein in Patients with Vascular Dementia
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Objectives: To determine the relationships between Chlamydia pneumoniae infection, carotid atherosclerosis, and dyslipidemia in patients with vascular dementia (VaD) and Alzheimer's disease (AD). Design: Case control study. Setting: Showa University Karasuyama Hospital, Tokyo, Japan. Participants: One hundred twenty‐four elderly subjects: 31 with VaD, 61 with AD, and 32 age‐matched controls without dementia. Mesurements: Presence of antibodies to C. pneumoniae (immunoglobulin G (IgG) and IgA), the serum concentrations of high‐sensitive C‐reactive protein (hs‐CRP) and atherogenic lipoproteins, and the carotid artery intima‐media thickness (IMT) and plaques were determined. Results: Age; body mass index; systolic and diastolic blood pressures; and fasting plasma glucose, hemoglobin A 1c , high‐density lipoprotein cholesterol, and apolipoprotein A‐I, B, and E concentrations did not differ significantly between the three groups, but the mean IMT and frequency of atherosclerotic plaques in the carotid arteries, as well as the serum concentrations of low‐density lipoprotein cholesterol (LDL‐C), lipoprotein(a), and lipid peroxides were significantly greater in VaD patients than in AD patients or nondemented controls. Hs‐CRP concentrations and prevalence of C. pneumoniae IgG and IgA antibodies also were significantly higher in VaD patients than in AD patients and nondemented controls. Multiple logistic regression analysis revealed that carotid IMT and plaques, LDL‐C, lipid peroxides, hs‐CRP, and IgG and IgA C. pneumoniae seropositivity were independent risk factors for VaD. Conclusion: These results suggest that carotid atherosclerosis, atherogenic lipoproteins, and C. pneumoniae infection (as documented by the IgG and IgA seropositivity together with increased hs‐CRP) may be VaD risk factors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
Balin, B. J., Gérard, H. C., Arking, E. J., Appelt, D. M., Branigan, P. J., Abrams, J. T., Whittum-Hudson, J. A., & Hudson, A. P. (1998) · Medical Microbiology and Immunology · doi:10.1007/s004300050071 · Cited by 506 · cited 4×
“A previous study showed that one-third of patients with AD exhibit vascular lesions and a similar proportion of patients with VaD have pathological changes consistent with AD.63 Results from the Honolulu Asia Aging Study suggest that most demented men of Asian ancestry, regardless of the clinical diagnosis, may have A…”
BackgroundInfluentialCerebrovascular Pathology and Dementia in Autopsied Honolulu‐Asia Aging Study Participants
WHITE, L., PETROVITCH, H., HARDMAN, J., NELSON, J., DAVIS, D. G., ROSS, G. W., MASAKI, K., LAUNER, L., & MARKESBERY, W. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04794.x · Cited by 357 · cited 3×
“The subset of vascular lesions that are imagable using CT and used here to define VaD may not represent the true cause of cognitive impairment in these subjects.(64) Thus, the association between C.”
BackgroundInfluentialFailure To Detect Chlamydia pneumoniae in the Late-Onset Alzheimer's Brain
Ring, R. H., & Lyons, J. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.7.2591-2594.2000 · Cited by 81
Research works printed but not linked: 63
- 10.1016/S0021-9150(99)00003-9 · DOI
- 10.1002/(SICI)1096-9896(200002)190:3<237::AID-PATH541>3.0.CO;2-N · doi:10.1002/(sici)1096-9896(200002)190:3<237::aid-path541>3.0.co;2-n
- 10.1161/01.STR.0000089920.93927.A7 · DOI · Paper page
- 10.1536/jhj.43.607 · DOI
- 10.1001/jama.285.19.2481 · DOI · Paper page
- 10.1161/01.STR.31.7.1526 · DOI
- 10.1161/01.CIR.98.7.628 · DOI · Paper page
- 10.1016/S0140-6736(88)90741-6 · DOI · Paper page
- 10.1086/315596 · DOI · Paper page
- 10.1161/01.CIR.103.11.1503 · DOI
- 10.1161/01.STR.29.2.404 · DOI · Paper page
- 10.1161/01.STR.27.12.2207 · DOI · Paper page
- 10.1161/01.STR.31.7.1521 · DOI · Paper page
- Fagerberg B, 1999, Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease, A prospective study in middle-aged to elderly men with treated hypertension, 30, 299
- 10.1016/j.metabol.2003.11.020 · DOI
- 10.1159/000077812 · DOI
- Roman GC, 1993, Vascular dementia: Diagnostic criteria for research studies, Report of the NINDS-AIREN International Workshop, 43, 250
- 10.1212/WNL.34.7.939 · DOI · Paper page
- Mori E, 1985, Usefulness of a Japanese version of the Mini‐Mental State Test in neurological patients, Jpn J Neuropsychol, 1, 82
- Homma A., 1992, Assessment and treatment of patients with dementia of the Alzheimer's type, Nippon Ronen Igakkai Zasshi, 29, 264
- 10.1212/WNL.49.3.690 · DOI · Paper page
- Friedewald WT, 1972, Estimation of the concentration of low‐density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem, 18, 488, 10.1093/clinchem/18.6.499 · DOI · Paper page
- 10.1291/hypres.26.541 · DOI
- Kishimoto T, 1996, Assay of specific anti‐Chlamydia pneumoniae antibodies by ELISA method, 1. Evaluation of ELISA kit using outer membrane complex, 70, 821
- Kishimoto T, 1999, Assay of specific anti‐Chlamydia pneumoniae antibodies by ELISA method, 3. Setting of serological criteria, 73, 457
- 10.1016/S0895-7061(03)00985-3 · DOI
- Chambless LE, 2000, Carotid wall thickness is predictive of incident clinical stroke, The Atherosclerosis Risk in Communities (ARIC) Study, 151, 478
- 10.1161/01.STR.32.8.1780 · DOI
- 10.1161/01.STR.0000089015.51603.CC · DOI · Paper page
- 10.1161/01.HYP.31.2.589 · doi:10.1161/01.hyp.31.2.589
- Kazmierski R, 2002, Effect of Chlamydia pneumoniae infection on carotid atherosclerosis development, Neurol Neurochir Pol, 36, 131
- 10.1161/01.STR.32.4.855 · DOI
- 10.3201/eid0404.980407 · DOI · Paper page
- 10.1161/hs1201.099631 · DOI
- 10.1161/hs0901.094290 · DOI
- 10.1016/S0197-4580(02)00236-1 · DOI
- Balin BJ, 2001, Role of infection in Alzheimer's disease, J Am Osteopath Assoc, 101, S1
- 10.1046/j.1468-1331.2002.00408.x · doi:10.1046/j.1468-1331.2002.00408.x
- Heuschmann PU, 2001, Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes, Results from a population-based case-control study, 32, 2253
- 10.1161/01.CIR.103.10.1390 · DOI
- 10.1161/01.STR.0000014562.75483.6B · doi:10.1161/01.str.0000014562.75483.6b
- 10.1007/s10096-001-0647-3 · doi:10.1007/s10096-001-0647-3
- Gurfinkel E, 1998, Chlamydia pneumoniae, Inflammation and instability of the atherosclerotic plaque, 140, S31
- 10.1161/01.CIR.103.12.1613 · DOI
- 10.1086/514241 · DOI · Paper page
- 10.1128/IAI.65.11.4832-4835.1997 · DOI · Paper page
- 10.1128/IAI.68.6.3635-3641.2000 · doi:10.1128/iai.68.6.3635-3641.2000
- 10.1159/000070708 · DOI
- 10.1002/art.1780350824 · DOI · Paper page
- 10.1161/01.CIR.98.4.300 · DOI · Paper page
- 10.1086/314931 · DOI
- Gao H, 2001, Clinical study on treatment of senile vascular dementia by acupuncture, J Tradit Chin Med, 21, 103
- 10.1016/0304-3940(94)90122-8 · DOI
- Schmidt R, 2002, Early inflammation and dementia, A 25-year follow-up of the Honolulu-Asia aging study, 52, 168
- Melissano G, 1999, Chlamydia pneumoniae eradication from carotid plaques, Results of an open, randomised treatment study, 18, 355
- 10.1161/01.CIR.0000036748.26775.8D · DOI
- Wiesli P, 2002, Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men, A randomized, double-blind, placebo-controlled trial, 105, 2646
- O'Connor CM, 2003, Azithromycin for the secondary prevention of coronary heart disease events: The WIZARD study, A randomized controlled trial, 290, 1459
- Gelfand EV, 2004, Antibiotics for secondary prevention of coronary artery disease, An ACES hypothesis but we need to PROVE IT, 147, 202
- 10.1159/000077737 · DOI
- Kalaria RN., 2002, Small vessel disease and Alzheimer's dementia, Pathological considerations, 13, 48
- Royall DR., 2002, Vascular Cognitive Impairment, 307
- Graham NL, 2004, Distinctive cognitive profiles in Alzheimer's disease and subcortical vascular dementia, J Neurol Neurosug Psychiatry, 75, 61
Cited by
A Meta-Analysis of Cytokines in Alzheimer's Disease
Swardfager, W., Lanctôt, K., Rothenburg, L., Wong, A., Cappell, J., & Herrmann, N. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.012 · Cited by 1,108
Pathology and pathogenesis of vascular cognitive impairment—a critical update
Jellinger, K. A. (2013) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2013.00017 · Cited by 353
“Other studies suggest potential roles of inflammation in VCI (Yamamoto et al., 2005).”
BackgroundThe Viral Hypothesis in Alzheimer’s Disease: Novel Insights and Pathogen-Based Biomarkers
Naughton, S. X., Raval, U., & Pasinetti, G. M. (2020) · Journal of Personalized Medicine · doi:10.3390/jpm10030074 · Cited by 30
“pneumoniae have been detected in patients with vascular dementia [42].”
Background
Metadata
- Authors
- Yamamoto, H., Watanabe, T., Miyazaki, A., Katagiri, T., Idei, T., Iguchi, T., Mimura, M., & Kamijima, K.
- Venue
- Journal of the American Geriatrics Society
- Publisher
- Wiley
- Published
- 2005-03-30
- Volume
- 53
- Issue
- 4
- Pages
- 583-589
- ISSN
- 0002-8614 (ISSN-L)
- 1532-5415
- OpenAlex
- W1543337454
- Cited by
- 42
- References
- 3
- FWCI
- 1.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High‐Sensitive C‐Reactive Protein in Patients with Vascular Dementia. https://app.cochat.ai/papers/10.1111/j.1532-5415.2005.53204.x
- The paper
- Yamamoto, H., Watanabe, T., Miyazaki, A., Katagiri, T., Idei, T., Iguchi, T., Mimura, M., & Kamijima, K. (2005). High Prevalence of Chlamydia Pneumoniae Antibodies and Increased High‐Sensitive C‐Reactive Protein in Patients with Vascular Dementia. Journal of the American Geriatrics Society. https://doi.org/10.1111/j.1532-5415.2005.53204.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.